Similarly, upregulation of IGF1R/IRS and STAT3 signaling is frequently observed in HPV-negative R/M HNSCC, a population with particularly poor prognosis and limited treatment options [84,85]. The gene discussed is STAT3; the disease is head and neck squamous cell carcinoma.